{"cdcTestId":"2013-0475","testcaseName":"Dose 1 to dose 3 interval 16 weeks=valid when administered prior to 12/16/2016","vaccineGroup":"HPV","evaluationTestType":"Interval: At Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2008-08-08T00:00:00","patient":{"dob":"1996-03-21T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2008-04-18T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2008-05-16T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2008-08-08T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2008-04-18T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2008-05-16T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2008-08-08T00:00:00","vaccineName":"HPV, unspecified formulation","cvx":"137","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-15T08:57:50.904","generalDescription":"This test case describes when a adolescent child is administered a third dose of the HPV vaccine at 12 weeks after the second dose and at least 16 weeks - 4 days from dose number one, that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1).","changedInVersion":"1.0","reasonForChange":""}